BioLight Life Sciences

Bio-Light-Israeli LifeSciences Investments is an emerging global ophthalmology company focused on the discovery, development, and commercialization of products and product candidates addressing ophthalmic diseases, including glaucoma, dry eye syndrome (DES), and age-related macular degeneration (AMD). The company’s current products and candidates aim to meet the needs of a large and growing patient population affected by these ophthalmic conditions by reducing non-compliance with medication management, improving treatment efficacy and safety, and providing better diagnostics.